NCT06477263View on ClinicalTrials.gov

NeuroCytotron in the Treatment of Autism Spectrum Disorder

NARecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

July 15, 2024

Primary Completion Date

March 6, 2025

Study Completion Date

September 30, 2025

Conditions

Autism Spectrum Disorder

Interventions

DEVICE

Neurocytotron

Neuronal regeneration treatment

Trial Locations (1)

66224

RECRUITING

NeuroCytonix México, San Pedro Garza García

All Listed Sponsors

lead

Neurocytonix, Inc.

INDUSTRY